22 results
Keyword Methoxsalen Remove keyword
-
List item
Orphan designation: Methoxsalen for: Treatment of graft-versus-host disease
Date of designation: 22/05/2006, Positive, Last updated: 21/05/2019Methoxsalen Overview On 22 May 2006 … Ltd, United Kingdom, for methoxsalen for the treatment of graft-versus-host … medicine expected to work? Methoxsalen is pharmacologically active … -
List item
Human medicine European public assessment report (EPAR): Klisyri
tirbanibulin, Keratosis, Actinic
Date of authorisation: 16/07/2021,, Revision: 1, Authorised, Last updated: 19/01/2022
-
List item
Human medicine European public assessment report (EPAR): Revlimid
lenalidomide, Multiple Myeloma; Lymphoma, Mantle-Cell; Myelodysplastic Syndromes
Date of authorisation: 14/06/2007,, Revision: 48, Authorised, Last updated: 06/12/2022
-
List item
Human medicine European public assessment report (EPAR): Teysuno
tegafur, gimeracil, oteracil, Stomach Neoplasms
Date of authorisation: 14/03/2011, Revision: 21, Authorised, Last updated: 04/04/2022 -
List item
COMP: Agendas, minutes and meeting reports (updated)
Last updated: 01/02/2023 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 September 2018
European Medicines Agency, London, UK, from 11/09/2018 to 13/09/2018, Last updated: 06/12/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 5-7 December 2017
European Medicines Agency, London, UK, from 05/12/2017 to 07/12/2017, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 June 2018
European Medicines Agency, London, UK, from 19/06/2018 to 21/06/2018, Last updated: 17/08/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 January 2018
European Medicines Agency, London, UK, from 16/01/2018 to 18/01/2018, Last updated: 19/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 February 2018
European Medicines Agency, London, UK, from 13/02/2018 to 15/02/2018, Last updated: 19/02/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 4-6 October 2016
European Medicines Agency, London, UK, from 04/10/2016 to 06/10/2016, Last updated: 17/07/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 July 2016
European Medicines Agency, London, UK, from 11/07/2016 to 13/07/2016, Last updated: 17/06/2014 -
List item
Risks associated with furocoumarins contained in preparations of Angelica archangelica L. - Scientific guideline
Last updated: 31/10/2007 -
List item
ICH S10 Photosafety evaluation of pharmaceuticals - Scientific guideline
Last updated: 31/01/2014 -
List item
Periodic safety update reports (PSURs)
Last updated: 27/07/2022 -
List item
News: Feedback requested on the draft list of EU reference dates for periodic safety update reports in preparation for introduction of the new pharmacovigilance legislation
Last updated: 04/04/2012 -
List item
Guidance documents
Last updated: 19/07/2022 -
List item
Annual reports and work programmes
Last updated: 10/06/2022 -
List item
Pharmacovigilance: Regulatory and procedural guidance
Last updated: 29/04/2016 -
List item
News: European Medicines Agency to begin PSUR assessment based on active substances in both centrally and nationally authorised medicines
Last updated: 27/03/2013 -
List item
News: European Medicines Agency publishes list of EU reference dates and frequency of PSUR submission
Last updated: 01/10/2012